Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
25.86% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NAGE · Mar 31, 2025
Niagen Bioscience, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-25-023127General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
37.59% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
36.69% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
63.42% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
15.66% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.13% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
3.53% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History17 statesSelf-history eligible
Jun 30, 20220/6 normalizedLevel 3Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20230/6 normalizedLevel 3Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20246/7 normalizedLevel 3Sep 30, 20246/7 normalizedLevel 3Dec 31, 20246/7 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 12.16%
- Current
- 25.86%
- Delta
- 13.70%
- Previous
- 19.18%
- Current
- 37.59%
- Delta
- 18.42%
- Previous
- 9.23%
- Current
- 36.69%
- Delta
- 27.47%
- Previous
- 61.84%
- Current
- 63.42%
- Delta
- 1.58%
- Previous
- 7.76%
- Current
- 15.66%
- Delta
- 7.90%
- Previous
- 6.04%
- Current
- 4.13%
- Delta
- -1.91%
- Previous
- 3.67%
- Current
- 3.53%
- Delta
- -0.14%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · NAGE Fundamental State →Analogous To · NAGE state analogue 4 →Has State · Niagen Bioscience, Inc. →Transitioned To · NAGE Fundamental State →Transitioned To · NAGE CASH_GENERATION_INCREASED →Transitioned To · NAGE GROWTH_INCREASED →Transitioned To · NAGE INVENTORY_PRESSURE_INCREASED →Transitioned To · NAGE MARGIN_INCREASED →Transitioned To · NAGE PROFITABILITY_INCREASED →Transitioned To · NAGE R_AND_D_INTENSITY_DECREASED →Transitioned To · NAGE SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.